相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A theoretical framework for determining cerebral vascular function and heterogeneity from dynamic susceptibility contrast MRI
Ingrid Digernes et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Response Assessment in Neuro-Oncology Clinical Trials
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
IDH1-Mutation in Diffuse Gliomas in Persons Age 55 Years and Over
Chase Robinson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2017)
Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations
John C. DeWitt et al.
NEURO-ONCOLOGY (2017)
Clinical parameters outweigh diffusion- and perfusion-derived MRI parameters in predicting survival in newly diagnosed glioblastoma
Sina Burth et al.
NEURO-ONCOLOGY (2016)
Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients
Agne Ulyte et al.
NEURORADIOLOGY (2016)
Assessment of Progression-Free-Survival in Glioblastomas by Intratreatment Dynamic Contrast-Enhanced MRI
S. Bisdas et al.
CLINICAL NEURORADIOLOGY (2016)
Early changes in perfusion of glioblastoma during radio- and chemotherapy evaluated by T1-dynamic contrast enhanced magnetic resonance imaging
Soren Moller et al.
ACTA ONCOLOGICA (2015)
The Added Prognostic Value of Preoperative Dynamic Contrast-Enhanced MRI Histogram Analysis in Patients with Glioblastoma: Analysis of Overall and Progression-Free Survival
Y. S. Choi et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Prognostic Value of Dynamic Susceptibility Contrast-Enhanced and Diffusion-Weighted MR Imaging in Patients with Glioblastomas
G. Coban et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial
Kathleen M. Schmainda et al.
NEURO-ONCOLOGY (2015)
Standard chemoradiation for glioblastoma results in progressive brain volume loss
Morgan J. Prust et al.
NEUROLOGY (2015)
Pitfalls in le neuroimaging of glioblastoma in le era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response
Raymond Y. Huang et al.
FRONTIERS IN NEUROLOGY (2015)
Preoperative Prognostic Value of Dynamic Contrast-Enhanced MRI-Derived Contrast Transfer Coefficient and Plasma Volume in Patients with Cerebral Gliomas
T. B. Nguyen et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: Comparison of intraindividually matched T1- and T2*-based bolus techniques
David Bonekamp et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2015)
Vessel calibre-a potential MRI biomarker of tumour response in clinical trials
Kyrre E. Emblem et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral nnicroenvironment and is predictive of patient outcome
Randy L. Jensen et al.
NEURO-ONCOLOGY (2014)
Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma
Kathleen M. Schmainda et al.
NEURO-ONCOLOGY (2014)
Prognosis Prediction of Measurable Enhancing Lesion after Completion of Standard Concomitant Chemoradiotherapy and Adjuvant Temozolomide in Glioblastoma Patients: Application of Dynamic Susceptibility Contrast Perfusion and Diffusion-Weighted Imaging
Jae Hyun Kim et al.
PLOS ONE (2014)
Outcome Prediction in Patients with Glioblastoma by Using Imaging, Clinical, and Genomic Biomarkers: Focus on the Nonenhancing Component of the Tumor
Rajan Jain et al.
RADIOLOGY (2014)
Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy
Kyrre E. Emblem et al.
NATURE MEDICINE (2013)
Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapy
Benjamin M. Ellingson et al.
NEURO-ONCOLOGY (2013)
Radiation Therapy-Induced Tumor Invasiveness Is Associated with SDF-1-Regulated Macrophage Mobilization and Vasculogenesis
Shu-Chi Wang et al.
PLOS ONE (2013)
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
Tracy T. Batchelor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Genomic Mapping and Survival Prediction in Glioblastoma: Molecular Subclassification Strengthened by Hemodynamic Imaging Biomarkers
Rajan Jain et al.
RADIOLOGY (2013)
Correlation between Cerebral Blood Volume Measurements by Perfusion-Weighted Magnetic Resonance Imaging and Two Year Progression-Free Survival in Gliomas
M. V. Spampinato et al.
NEURORADIOLOGY JOURNAL (2013)
Correlations between Perfusion MR Imaging Cerebral Blood Volume, Microvessel Quantification, and Clinical Outcome Using Stereotactic Analysis in Recurrent High-Grade Glioma
L. S. Hu et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2012)
Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
A. Gregory Sorensen et al.
CANCER RESEARCH (2012)
Targeting SDF-1/CXCR4 to inhibit tumour vasculature for treatment of glioblastomas
D. Tseng et al.
BRITISH JOURNAL OF CANCER (2011)
NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES
Shom Goel et al.
PHYSIOLOGICAL REVIEWS (2011)
Recruitment of Myeloid but not Endothelial Precursor Cells Facilitates Tumor Regrowth after Local Irradiation
Sergey V. Kozin et al.
CANCER RESEARCH (2010)
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
Dora Dias-Santagata et al.
EMBO MOLECULAR MEDICINE (2010)
A fully automated method for quantitative cerebral hemodynamic analysis using DSC-MRI
Atle Bjornerud et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2010)
Phase II Study of Cediranib, an Oral Pan-Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
Tracy T. Batchelor et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Plasma Soluble VEGFR-1 Is a Potential Dual Biomarker of Response and Toxicity for Bevacizumab with Chemoradiation in Locally Advanced Rectal Cancer
Dan G. Duda et al.
ONCOLOGIST (2010)
Changes in Relative Cerebral Blood Volume 1 Month after Radiation-Temozolomide Therapy Can Help Predict Overall Survival in Patients with Glioblastoma
Rajiv Mangla et al.
RADIOLOGY (2010)
Monoclonal antibody specific for IDH1 R132H mutation
David Capper et al.
ACTA NEUROPATHOLOGICA (2009)
Cerebral Blood Volume Measurements by Perfusion-Weighted MR Imaging in Gliomas: Ready for Prime Time in Predicting Short-Term Outcome and Recurrent Disease?
S. Bisdas et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2009)
A Vascular Normalization Index as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
A. Gregory Sorensen et al.
CANCER RESEARCH (2009)
The parametric response map is an imaging biomarker for early cancer treatment outcome
Craig J. Galban et al.
NATURE MEDICINE (2009)
Prognostic value of perfusion MR imaging of high-grade astrocytomas: Long-term follow-up study
T. Hirai et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
Gliomas: Predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging
Meng Law et al.
RADIOLOGY (2008)
Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI
Geoff J. M. Parker et al.
MAGNETIC RESONANCE IN MEDICINE (2006)
Comparison of manual and automatic section positioning of brain MR images
T Benner et al.
RADIOLOGY (2006)
Low-grade gliomas: Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging - Prediction of patient clinical response
M Law et al.
RADIOLOGY (2006)
On-line automatic slice positioning for brain MR imaging
AJW van der Kouwe et al.
NEUROIMAGE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Comparison of diameter and perimeter methods for tumor volume calculation
AG Sorensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors
TL Chenevert et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
